ID   SYHM_HUMAN              Reviewed;         506 AA.
AC   P49590; B4DDY8;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=Probable histidine--tRNA ligase, mitochondrial;
DE            EC=6.1.1.21;
DE   AltName: Full=Histidine--tRNA ligase-like;
DE   AltName: Full=Histidyl-tRNA synthetase;
DE            Short=HisRS;
DE   Flags: Precursor;
GN   Name=HARS2; Synonyms=HARSL, HARSR, HO3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=7755634; DOI=10.1006/bbrc.1995.1696;
RA   O'Hanlon T.P., Raben N., Miller F.W.;
RT   "A novel gene oriented in a head-to-head configuration with the human
RT   histidyl-tRNA synthetase (HRS) gene encodes an mRNA that predicts a
RT   polypeptide homologous to HRS.";
RL   Biochem. Biophys. Res. Commun. 210:556-566(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-444, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   VARIANTS PRLTS2 VAL-200 AND LEU-368, CHARACTERIZATION OF VARIANTS
RP   PRLTS2 VAL-200 AND LEU-368, AND SUBUNIT.
RX   PubMed=21464306; DOI=10.1073/pnas.1103471108;
RA   Pierce S.B., Chisholm K.M., Lynch E.D., Lee M.K., Walsh T.,
RA   Opitz J.M., Li W., Klevit R.E., King M.C.;
RT   "Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause
RT   ovarian dysgenesis and sensorineural hearing loss of Perrault
RT   syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:6543-6548(2011).
CC   -!- CATALYTIC ACTIVITY: ATP + L-histidine + tRNA(His) = AMP +
CC       diphosphate + L-histidyl-tRNA(His).
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:21464306}.
CC   -!- INTERACTION:
CC       Q6RW13:AGTRAP; NbExp=3; IntAct=EBI-3909030, EBI-741181;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49590-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49590-2; Sequence=VSP_055133;
CC   -!- TISSUE SPECIFICITY: A high level expression is seen in the heart,
CC       kidney and skeletal muscle while a lower level expression is seen
CC       in the brain and liver.
CC   -!- DISEASE: Perrault syndrome 2 (PRLTS2) [MIM:614926]: A sex-
CC       influenced disorder characterized by sensorineural deafness in
CC       both males and females and ovarian dysgenesis in females. Affected
CC       females have primary amenorrhea, streak gonads, and infertility,
CC       whereas affected males show normal pubertal development and are
CC       fertile. {ECO:0000269|PubMed:21464306}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U18936; AAA73972.1; -; Genomic_DNA.
DR   EMBL; U18937; AAA73974.1; -; mRNA.
DR   EMBL; AK293390; BAG56899.1; -; mRNA.
DR   EMBL; AC116353; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW62019.1; -; Genomic_DNA.
DR   EMBL; BC007680; AAH07680.1; -; mRNA.
DR   EMBL; BC014982; AAH14982.1; -; mRNA.
DR   CCDS; CCDS4238.1; -. [P49590-1]
DR   CCDS; CCDS64267.1; -. [P49590-2]
DR   PIR; I38913; I38913.
DR   PIR; I38915; I38915.
DR   RefSeq; NP_001265660.1; NM_001278731.1. [P49590-2]
DR   RefSeq; NP_001265661.1; NM_001278732.1.
DR   RefSeq; NP_036340.1; NM_012208.3. [P49590-1]
DR   UniGene; Hs.432560; -.
DR   ProteinModelPortal; P49590; -.
DR   SMR; P49590; -.
DR   BioGrid; 117006; 35.
DR   DIP; DIP-59626N; -.
DR   IntAct; P49590; 8.
DR   STRING; 9606.ENSP00000230771; -.
DR   iPTMnet; P49590; -.
DR   PhosphoSitePlus; P49590; -.
DR   BioMuta; HARS2; -.
DR   EPD; P49590; -.
DR   MaxQB; P49590; -.
DR   PaxDb; P49590; -.
DR   PeptideAtlas; P49590; -.
DR   PRIDE; P49590; -.
DR   DNASU; 23438; -.
DR   Ensembl; ENST00000230771; ENSP00000230771; ENSG00000112855. [P49590-1]
DR   Ensembl; ENST00000508522; ENSP00000423616; ENSG00000112855. [P49590-2]
DR   GeneID; 23438; -.
DR   KEGG; hsa:23438; -.
DR   UCSC; uc003lgx.5; human. [P49590-1]
DR   CTD; 23438; -.
DR   DisGeNET; 23438; -.
DR   GeneCards; HARS2; -.
DR   HGNC; HGNC:4817; HARS2.
DR   HPA; HPA035941; -.
DR   MalaCards; HARS2; -.
DR   MIM; 600783; gene.
DR   MIM; 614926; phenotype.
DR   neXtProt; NX_P49590; -.
DR   OpenTargets; ENSG00000112855; -.
DR   Orphanet; 2855; Perrault syndrome.
DR   PharmGKB; PA29192; -.
DR   eggNOG; KOG1936; Eukaryota.
DR   eggNOG; COG0124; LUCA.
DR   GeneTree; ENSGT00390000005922; -.
DR   HOGENOM; HOG000018075; -.
DR   HOVERGEN; HBG002731; -.
DR   InParanoid; P49590; -.
DR   KO; K01892; -.
DR   OMA; LHYCENM; -.
DR   OrthoDB; EOG091G05P3; -.
DR   PhylomeDB; P49590; -.
DR   TreeFam; TF300652; -.
DR   BRENDA; 6.1.1.21; 2681.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   GeneWiki; HARS2; -.
DR   GenomeRNAi; 23438; -.
DR   PRO; PR:P49590; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000112855; -.
DR   CleanEx; HS_HARS2; -.
DR   ExpressionAtlas; P49590; baseline and differential.
DR   Genevisible; P49590; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:WormBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004821; F:histidine-tRNA ligase activity; IDA:WormBase.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:WormBase.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006427; P:histidyl-tRNA aminoacylation; IDA:WormBase.
DR   GO; GO:0006412; P:translation; NAS:UniProtKB.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   CDD; cd00859; HisRS_anticodon; 1.
DR   Gene3D; 3.40.50.800; -; 1.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR004154; Anticodon-bd.
DR   InterPro; IPR015807; His-tRNA-ligase.
DR   InterPro; IPR004516; HisRS/HisZ.
DR   InterPro; IPR033656; HisRS_anticodon.
DR   PANTHER; PTHR11476; PTHR11476; 1.
DR   Pfam; PF03129; HGTP_anticodon; 1.
DR   PIRSF; PIRSF001549; His-tRNA_synth; 1.
DR   SUPFAM; SSF52954; SSF52954; 1.
DR   TIGRFAMs; TIGR00442; hisS; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Aminoacyl-tRNA synthetase;
KW   ATP-binding; Complete proteome; Deafness; Disease mutation; Ligase;
KW   Mitochondrion; Nucleotide-binding; Phosphoprotein;
KW   Protein biosynthesis; Reference proteome; Transit peptide.
FT   TRANSIT       1     33       Mitochondrion. {ECO:0000255}.
FT   CHAIN        34    506       Probable histidine--tRNA ligase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000136336.
FT   MOD_RES      67     67       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     444    444       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ      37     61       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055133.
FT   VARIANT     200    200       L -> V (in PRLTS2; the mutant protein is
FT                                expressed, can dimerize and localizes to
FT                                the mitochondria; has significantly
FT                                decreased enzymatic activity compared to
FT                                wild-type; dbSNP:rs397515410).
FT                                {ECO:0000269|PubMed:21464306}.
FT                                /FTId=VAR_069532.
FT   VARIANT     368    368       V -> L (in PRLTS2; the mutant protein is
FT                                expressed, can dimerize and localizes to
FT                                the mitochondria; has significantly
FT                                decreased enzymatic activity compared to
FT                                wild-type; dbSNP:rs376177973).
FT                                {ECO:0000269|PubMed:21464306}.
FT                                /FTId=VAR_069533.
SQ   SEQUENCE   506 AA;  56888 MW;  E1CE879837AE26E7 CRC64;
     MPLLGLLPRR AWASLLSQLL RPPCASCTGA VRCQSQVAEA VLTSQLKAHQ EKPNFIIKTP
     KGTRDLSPQH MVVREKILDL VISCFKRHGA KGMDTPAFEL KETLTEKYGE DSGLMYDLKD
     QGGELLSLRY DLTVPFARYL AMNKVKKMKR YHVGKVWRRE SPTIVQGRYR EFCQCDFDIA
     GQFDPMIPDA ECLKIMCEIL SGLQLGDFLI KVNDRRIVDG MFAVCGVPES KFRAICSSID
     KLDKMAWKDV RHEMVVKKGL APEVADRIGD YVQCHGGVSL VEQMFQDPRL SQNKQALEGL
     GDLKLLFEYL TLFGIADKIS FDLSLARGLD YYTGVIYEAV LLQTPTQAGE EPLNVGSVAA
     GGRYDGLVGM FDPKGHKVPC VGLSIGVERI FYIVEQRMKT KGEKVRTTET QVFVATPQKN
     FLQERLKLIA ELWDSGIKAE MLYKNNPKLL TQLHYCESTG IPLVVIIGEQ ELKEGVIKIR
     SVASREEVAI KRENFVAEIQ KRLSES
//
